← Browse by Condition
Medical Condition
liposarcoma
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2, Phase 1, Phase 2
NCT07169344 Phase 2
Recruiting
Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma
Enrollment
110 pts
Location
Norway
Sponsor
Oslo University Hospital
NCT06277154 Phase 2
Recruiting
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
Enrollment
148 pts
Location
China
Sponsor
HRYZ Biotech Co.
NCT06541262 Phase 1, Phase 2
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Enrollment
104 pts
Location
United States, Canad...
Sponsor
Milton S. Hershey Medical Cent...
NCT06239272 Phase 1, Phase 2
Recruiting
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Enrollment
139 pts
Location
United States
Sponsor
St. Jude Children's Research H...
NCT07432932
Recruiting
Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients
Enrollment
800 pts
Location
United Kingdom
Sponsor
Royal Marsden NHS Foundation T...